Ocrevus 300 mg/10 mL (30 mg/mL) single-dose vial Images

Generic Name: ocrelizumab

This medication has been identified as Ocrevus 300 mg/10 mL (30 mg/mL) single-dose vial. It is supplied by Genentech, Inc.

Ocrevus is used in the treatment of Multiple Sclerosis and belongs to the drug class CD20 monoclonal antibodies. Ocrevus 300 mg/10 mL (30 mg/mL) single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Ocrevus

Generic Name

ocrelizumab

Strength

300 mg/10 mL (30 mg/mL) single-dose vial

Availability

Prescription only

Drug Class

CD20 monoclonal antibodies

CSA Schedule

Not a controlled drug

Labeler / Supplier

Genentech, Inc.

National Drug Code (NDC)

50242-0150

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer